Metformin Therapy Center

Pharmacological interventions may have a role to play in preventing progression to type 2 diabetes, but are they more important than lifestyle factors?

First study to examine whether the diabetes drug may have anti-inflammatory properties that affect varicose vein risk.

Study finds U.S. patients of Asian ancestry are experiencing delays in treatment augmentation when they haven’t met the recommended hemoglobin A1c goals. 

Could metformin potentially be the first medication approved to PREVENT dementia?

How does Imeglimin perform in combination with metformin in patients with type 2 diabetes?

Evidence has shown diabetic treatment options to improve beta-cell function and/or insulin sensitivity, but do these effects persist upon treatment withdrawal?

Which baseline clinical characteristics of patients with newly diagnosed diabetes lead us to providing more personalized care?

Which groups get the most benefit in diabetes prevention from using metformin?

Another medication taken for type 2 diabetes may also help reverse a potentially life-threatening heart condition.

This is not the first study showing these negative effects of metformin.